SOLB Solvay SA

Solvay withdraws its full-year guidance and calls on all investors to contribute one third of final dividend to a new COVID-19 Solvay solidarity fund

Solvay withdraws its full-year guidance and calls on all investors to contribute one third of final dividend to a new COVID-19 Solvay solidarity fund

Regulated information / inside information



Brussels, April 9, 2020, 7.30am CET – Solvay today announced a financial update related to the COVID-19 global pandemic.  Due to heightened uncertainty and prolonged duration of events, the Group is withdrawing its full year 2020 guidance issued on February 26, 2020.  Further, Solvay confirmed its dividend recommendation, highlighting the strength of its cash flow generation, balance sheet, and liquidity.  Solvay also announced plans to launch a solidarity fund to support employees and their dependents who experience hardship as a direct result of COVID-19.

“During these challenging times, we are mobilized and we are taking decisive action on matters that are within our control, especially protecting our people, meeting customer needs, and prioritizing cash generation and cost reduction,” said Ilham Kadri, chief executive officer.  “We are deleveraging pension liabilities and are  reducing our capital expenditure by over €250 million in 2020.  Our balance sheet strength – with liquidity reserves of around €4 billion comprised of cash and undrawn credit facilities – and our focus on cash-flow generation gives me confidence that Solvay is able to navigate this period effectively.” continued Ms. Kadri.

The company confirms that it will maintain its total dividend recommendation of €3.75 gross per share, on the back of the strong 2019 results announced on 26 February 2020.   This leads to a final gross dividend of €2.25 per share payable on May 20, 2020, which follows the interim dividend payment in January 2020 of €1.50 per share.

Solvay also announced plans to establish a to support Solvay employees and dependents who may experience hardship related to COVID-19.  Senior management have unanimously volunteered to contribute 15% of their salary for the remainder of the year,  and the Group will match all employee contributions.  Upon management’s recommendation, the Board approved and calls on all shareholders to contribute one third of their final dividend (equivalent to €0.75 per share) towards that Fund.

“I want to thank Solvay’s employees for their commitment to keeping our key activities operational and safe in service of our customers during these challenging times. Solvay products are more than ever essential to daily lives in a number of markets such as healthcare, food and consumer goods.    I am confident that Solvay will emerge stronger when economic conditions improve.” said Ms. Kadri.

 

Attachment

EN
09/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

Stijn Demeester
  • Stijn Demeester

Solvay/Expectations reset, yield remains attractive/BUY

We update our model and lower our Und. EBITDA estimates by c.12% to reflect Solvay's 2Q25 results and lowered guidance. We reduce our target price to €30 per share from €33.50 yet keep our BUY on the back of Solvay's attractive dividend yield.

Solvay SA: 1 director

A director at Solvay SA bought 1,083 shares at 27.740EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Wim Hoste
  • Wim Hoste

Solvay Feedback conference call

Below are the key highlights from the conference call. Solvay's 1Q25 uEBITDA dropped 15% to € 230m, in line with the recent profit warning. Solvay reiterated the (recently cut) FY25 underlying EBITDA guidance of € 880-930m (c. -12% at midpoint vs the previous € 1.0-1.05bn range), citing continued soft demand in a context of tariff and geopolitical uncertainty. Solvay had already stated to maintain FCF guidance of c. € 300m (on the back of more prudent capex spending) which however still means th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch